Skip to main content
Clinical Biofabrication Platform

BIOPRINTING &
HUMAN TISSUE
REGENERATION

Advanced bioprinting systems engineered for personalized tissue restoration, drug discovery, and clinical cell delivery.

OUR PURPOSE

Rebuilding Human Tissue.
Eliminating the Wait List.

Every year, thousands die waiting for organs that never arrive. Celutron exists to end that wait — by growing tissue from your own cells.

PRINT

We bioprint living tissue structures layer by layer — with the same precision a surgeon needs, and the speed a patient can't afford to lose.

PERSONALISE

Every scaffold, every bioink, every membrane is built from the patient's own stem cells. No donors. No waiting. No rejection.

RESTORE

From bone reconstruction to organ repair — our tissue systems are designed to dissolve as the body heals, leaving nothing artificial behind.

SCIENCE

Every construct begins with three fundamentals.

NUCLEUSMEMBRANE
[ LIVING STEM CELLS ]
VIABLE CELLS
VIABILITY: >85%
SOURCE: PATIENT iPSC
DENSITY: 10⁶ - 10⁸ / ML
STATUS: HEALTHY
THE BIOLOGICAL ENGINE
01
CELLSiPSC

THE BIOLOGICAL ENGINE - MIN. VIABLE CELL SURVIVAL

  • Sourced from patient biopsy, iPSCs, or allogeneic stem cell lines.
  • Utilizes chondrocytes, osteoblasts, fibroblasts, or endothelial cells.
  • Formulated at densities between 10⁶ and 10⁸ cells/mL.
  • Maintains high cell viability under post-extrusion shear stress.
Validated Metric
>0% Post-Print Viability
EMBEDDED CELLSdECM MATRIX
[ BIOINK EXTRUSION ]
GMP GELATIN / dECM
STANDARD: dECM MATRIX
CROSSLINK: GELMA / ALGINATE
FLOW: STABLE
BIOCOMPATIBLE: 100%
THE LIVING MATERIAL
02
BIOINKdECM

THE LIVING MATERIAL - GOLD STANDARD MATRIX

  • Hydrogel carrier composed of GelMA, alginate, or fibrin.
  • Decellularized extracellular matrix (dECM) for biocompatibility.
  • Rheological properties optimized for shape fidelity.
  • Non-toxic, ionic or photo-curing crosslinking mechanism.
Validated Metric
dECM Gold Standard
100–500 µm PORE
[ REAL TISSUE SCAFFOLD MESH ]
SQUARE PORE GRID
HARD TISSUE: 100–500 µm
BORDER: CONTINUOUS LOOP
MATERIAL: PCL / HYDROGEL
LAYERS: 0° / 90° CROSS
THE STRUCTURAL BLUEPRINT
03
SCAFFOLD100 MM

THE STRUCTURAL BLUEPRINT - CRITICAL MIN. PORE SIZE

  • Provides 3D architecture for cell ingrowth and vascularization.
  • Pore sizes between 100-500 µm for load-bearing structures.
  • Custom geometry designed from patient MRI or CT scans.
  • Bioresorbable materials (PCL, PLGA) degrade safely over time.
Validated Metric
0–500µm Hard / 20–100µm Soft
OUR PLATFORM

A bioprinter built for the lab bench.

Load your bioink. Set your structure. Press print.

BioTron builds living tissue layer by layer at 10µm precision — inside a sealed sterile chamber, automatically.

No special training. No cleanroom required.

BioTron V2 Desktop 3D Bioprinter
SYSTEM STATUS: READY
APPLICATIONS

What we are building towards.

Our technology platform is directed towards engineering functional biological structures, aiming to replace complex tissues and diagnostic systems.

01

Bone Reconstruction

Patient-specific implants and bone scaffold systems

Utilizing biocompatible calcium phosphate composite bioinks to print rigid structures that stimulate natural bone growth and osteointegration, eventually resorbing as the bone heals.

Bone Reconstruction
Osteoconduction
98.4%
Pore Diameter
150-300µm
Comp. Strength
12.5 MPa
02

Wound Healing

Exosome-loaded membranes for chronic diabetic wounds

A cellular patch embedded with concentrated stem cell-derived exosomes to stimulate cellular signaling, accelerating angiogenesis and tissue repair in chronic wounds.

Wound Healing
Angiogenesis
+320%
Cell Migration
1.8x Speed
Release Window
72 Hours
03

Organ Repair

Kidney tissue biofabrication and organ construct research

High-precision microfluidic extrusion printing of renal proximal tubules to model toxicological responses and research complex multicellular organ architectures.

Organ Repair
Print Precision
10µm
Cell Viability
94.2%
Tubule Length
12.5mm
04

Drug Delivery

Nanoconjugate systems for controlled therapeutic release

Custom biodegradable polymer nanocarriers conjugated with targeted ligands to release therapeutic payloads locally, minimizing systemic toxicities.

Drug Delivery
Targeting Index
92.6
Degradation Half-Life
48h
Loading Efficiency
88.1%
05

Maxillofacial

Bioresorbable fixation implants from DICOM CT imaging

Patient-matched bone fixation plates designed from clinical DICOM scans, printed using bioresorbable polymers to eliminate the need for secondary removal surgeries.

Maxillofacial
CT Match Accuracy
<0.1mm
Resorption Time
12 Months
Tensile Modulus
2.4 GPa
06

Cancer Diagnostics

Non-invasive patch sensors and cytogenetic mapping

Highly sensitive micro-electrode arrays embedded in comfortable skin patches, monitoring protein biomarkers and cellular fragments in real-time to detect oncogenic changes.

Cancer Diagnostics
LOD Sensitivity
1.2 pg/mL
Sensor Density
64 ch/cm²
Latency
<150ms
CLINICAL-GRADE SOLUTIONS

What We Provide

Comprehensive bioprinting solutions engineered for precision, reliability, and clinical excellence

01

Bioprinting Systems

State-of-the-art 3D bioprinting platforms engineered for precision tissue fabrication and cellular architecture.

Multi-material extrusion
Automated calibration
Real-time monitoring
Learn more
02

Bioink Supply

Clinical-grade bioinks formulated for optimal cell viability, printability, and tissue-specific applications.

GMP-certified materials
Custom formulations
Quality assurance
Learn more
03

Scaffold Fabrication

Advanced scaffold manufacturing services delivering precise geometries for tissue engineering applications.

Custom architectures
Biocompatible materials
Sterile processing
Learn more
04

Research Collaboration

Strategic partnerships with academic and industry leaders to advance bioprinting technology and applications.

Joint development
IP protection
Resource sharing
Learn more
05

Clinical Translation

Comprehensive support for translating bioprinting innovations from laboratory to clinical implementation.

Regulatory guidance
Clinical trials
Market strategy
Learn more
Clinical Research

Validated. Peer-reviewed. Clinically directed.

SCB-Nanocellulose Bioprinting Matrix

Existing CNF models use harsh chemicals & fail to use bagasse waste.

DES: 155.8nm
Zeta: -20.6mV

Bone Scaffold

Mono-component alginate shows poor load profile for orthopedic defects.

28x Compressive
72.3% Porosity

Exosome Wound Healing Membrane

Chronic diabetic wounds show delayed healing due to damaged angiogenesis.

i-PRF Matrix
MTT Validated
ECOSYSTEM & PARTNERS

Collaborations & Key Ecosystem Partners

Celutron collaborates with premier medical universities, incubation centres, clinical institutions, and government bodies to pioneer bioprinting technology.

INCUBATION
Crescent Innovation & Incubation Centre (CIIC)
VIT Vellore
Startup India
Crescent University
VS Hospitals
Yenepoya University, Mangalore
INCUBATION
Crescent Innovation & Incubation Centre (CIIC)
VIT Vellore
Startup India
Crescent University
VS Hospitals
Yenepoya University, Mangalore
JOINT SCIENTIFIC VENTURES

Ready to collaborate?

Whether you're a researcher, hospital, or investor — let's build something that matters.